Diabetech - Diabetes Tech, Research, and News

Justin Eastzer
  • 4.7 (35)
  • MEDICINE
  • UPDATED WEEKLY
Diabetech - Diabetes Tech, Research, and News

Breaking down diabetes tech, research, and future innovations -- and what it means for you.

  1. 4D AGO

    How A Diabetes Blogger Changed The Game

    In this episode, I sit down with Amy Tenderich, one of the first diabetes bloggers, whose open letter to Steve Jobs called for better, more user-friendly diabetes technology. That bold move launched her deeper into the world of diabetes advocacy and innovation, eventually leading her to create D-Data Exchange—a powerful forum where industry leaders, regulators, and patient voices come together to push diabetes tech forward. We talk about what it was like advocating before social media, the origins of the “We Are Not Waiting” movement, and how D-Data is now helping shape critical conversations—like the one I’ll be moderating this June at ADA on GLP-1s.   Learn about Omnipod 5 (today's sponsor)*   T1D Exchange Registry Sign up  (US residents only)   Watch This Episode On Youtube   Join our Newsletter | Support us on Patreon    Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

    53 min

  2. APR 14

    This Could Prevent Type 1 Diabetes - SAB-142 Explained

    Can we stop type 1 diabetes before it starts? I’m joined by Sam Reich, CEO of SAB Bio, and Dr. Mike Haller, a leading T1D researcher, to explore an innovative new therapy called SAB-142. Unlike traditional thymoglobulin, which is derived from rabbits, SAB’s therapy uses a fully human version produced by genetically engineered cows—potentially eliminating harmful side effects like serum sickness. We unpack how this treatment could delay or prevent the onset of type 1 diabetes and how it builds on research behind Teplizumab. Plus, we talk about the pivotal role NIH funding plays in advancing diabetes innovation. If you're curious about the future of diabetes prevention, you won’t want to miss this.   Learn about Omnipod 5 (today's sponsor)*   T1D Exchange Registry Sign up  (US residents only)   Watch This Episode On Youtube   Join our Newsletter | Support us on Patreon    Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

    1h 12m

  3. APR 7

    Getting Started on AAPS - The Open Source AID for Android

    We explore Android APS (AAPS)—a powerful open-source automated insulin delivery system that runs on Android phones and uses the advanced o-ref algorithm. AAPS offers features like Dynamic ISF (Insulin Sensitivity Factor), Dynamic CR (Carb Ratio), Unannounced Meal detection (UAM), and Super Micro Boluses (SMBs), making it one of the most customizable diabetes tech options out there. Our guest, Austin Sympson, a competitive cyclist with type 1 diabetes, shares his experience after three months on AAPS and what it's like getting started. We dive into why he switched from commercial systems, the setup process, and how he uses Temp Targets and his Garmin smartwatch to stay in range.     Learn about Omnipod 5 (today's sponsor)*   T1D Exchange Registry Sign up  (US residents only)   Watch This Episode On Youtube   Join our Newsletter | Support us on Patreon    Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

    1h 7m

  4. MAR 31

    The Twiist Pump is Coming - What You Need to Know

    The twiist insulin pump from Sequel Med Tech is releasing in Q2 of 2025. is bringing a new spin to tubed pump therapy. I met with Sequel's CEO to dive into twiist's launch CGM integration with Libre 3 Plus to its advanced occlusion technology designed for more reliable insulin delivery. We also break down how patients will access twiist through pharmacy benefit managers, a shift that could make the pump more accessible. For more coverage on the biggest diabetes tech announcements at ATTD, check out my social (@diabe_tech) and our recent podcast episode covering the biggest news!   Learn about Omnipod 5 (today's sponsor)*   T1D Exchange Registry Sign up  (US residents only)   Watch This Episode On Youtube   Watch Next: twiist First Look | twiist Explained   Join our Newsletter | Support us on Patreon    Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

    18 min

  5. MAR 24

    ATTD 2025: The Biggest Diabetes Tech Announcements

    Endocrinologist David Ahn and I break down the biggest diabetes tech announcements from the ATTD conference in Amsterdam! We dive into the highly anticipated Twiist pump, the newly unveiled and more powerful Kaleido 2, Tandem’s game-changing Control IQ+ algorithm update, Dexcom’s 15-day sensor, and more. This was a HUGE week for diabetes innovation—What are you most excited for? Let us know on Youtube!   Watch This Episode On Youtube   Learn about Omnipod 5 (today's sponsor)*   T1D Exchange Registry Sign up  (US residents only)   Join our Newsletter | Support us on Patreon    Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook   Follow David's Channels: Tik Tok | Instagram   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

    31 min

  6. MAR 17

    How the ADA Sets its Standards of Care for Diabetes

    The ADA’s Standards of Care shape diabetes treatment, technology access, and insurance coverage worldwide. In this episode, we break down the latest updates, including a major new recommendation that all people with type 2 diabetes—regardless of insulin use—have access to CGM. We also explore the ADA’s stance on emerging diabetes technologies and why these guidelines are considered the “gold standard” for diabetes management. Joining me is Dr. Grazia Aleppo, a leading endocrinologist and former Chair of the ADA’s Diabetes Technology Section, who shares insights into how these recommendations are developed and their impact on diabetes care.   Watch This Episode On Youtube   Learn about Omnipod 5 (today's sponsor)*   T1D Exchange Registry Sign up (US only)   Support Diabetech on Patreon  | Diabetech Community Discord   Follow me here: Instagram | Tik Tok | YouTube | Facebook   DISCLAIMERS: This podcast is not medical advice. Always consult with your doctor before making changes to your health care. *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

    49 min

  7. MAR 10

    Mastering Loop: The DIY Automated Insulin System

    DIY Loop is one of the most powerful and customizable automated insulin delivery systems for type 1 diabetes, offering features like overrides, retroactive carb adjustments, and glycemic index logging. In this episode, fellow Loop user Jake Giles joins me to share our experiences getting started, the support (or lack thereof) from doctors, and a deep dive into key features like carb logging by glycemic index, creating custom overrides, and pre-meal targets. Since Loop isn’t FDA-approved or available on the App Store, we also discuss the challenges of building and maintaining it. Plus, we answer your Instagram questions in a Q&A segment! Have questions? Drop them on the YouTube video!   Learn about Omnipod 5 (today's sponsor)*   Get Access to the DIY Loop Intro Guide + Join Newsletter   LoopDocs | Loop Facebook Group   T1D Exchange Registry Sign up (US only)   Support Diabetech on Patreon  | Diabetech Community Discord   Follow me here: Instagram | Tik Tok | YouTube | Facebook   Watch this Episode on Youtube   DISCLAIMERS: This podcast is not medical advice. Always consult with your doctor before making changes to your health care. DIY Loop is experimental and not approved by the FDA or regulatory authorities at the time of this video. You take full responsibility for building and using DIY Loop and you do so at your own risk. Results will vary.   *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

    1h 7m

  8. MAR 3

    Sernova's Type 1 Diabetes Cure Explained

    Sernova’s innovative Cell Pouch implants insulin-producing cells, and early trials have helped some people achieve full insulin independence for years. But challenges like immunosuppressants and scalability remain. In this episode, I’m joined by Jonathan Rigby, CEO of Sernova and a fellow T1D, to discuss how this technology works, the life-changing results from clinical trials, and the next steps in diabetes cure research. We explore stem cell-derived islet cells, gene-edited cells that could eliminate the need for immunosuppressants, and Sernova’s long-term vision for making a functional cure accessible.   Learn about Omnipod 5 (today's sponsor)*   T1D Exchange Registry Sign up (US only)   Read our Blog + Join the Newsletter    Support Diabetech on Patreon  | Diabetech Community Discord   Follow me here: Instagram | Tik Tok | YouTube | Facebook   Watch the Podcast on Youtube   DISCLAIMERS: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.   *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

    42 min
See All (101)

4.7
out of 5
35 Ratings

About

Breaking down diabetes tech, research, and future innovations -- and what it means for you.

Information

You Might Also Like

To listen to explicit episodes, sign in.

Stay up to date with this show

Sign in or sign up to follow shows, save episodes, and get the latest updates.
Select a country or region

Africa, Middle East, and India

Asia Pacific

Europe

Latin America and the Caribbean

The United States and Canada